Cargando…
Clinical approach to skin eruptions induced by anti-TNF agents among patients with inflammatory bowel diseases: insights from a multidisciplinary IBD-DERMA clinic
BACKGROUND AND AIMS: Skin eruptions are prevalent among patients with inflammatory bowel diseases (IBD), often associated with therapies and frequently leading to dermatological consults and treatment interruptions. We aimed to assess the impact of joint shared decision-making in a multidisciplinary...
Autores principales: | Yanai, Henit, Amir Barak, Hadar, Ollech, Jacob E, Avni Biron, Irit, Goren, Idan, Snir, Yifat, Banai Eran, Hagar, Broitman, Yelena, Aharoni Golan, Maya, Didkovsky, Elena, Amitay-Laish, Iris, Ollech, Ayelet, Hodak, Emmilia, Dotan, Iris, Pavlovsky, Lev |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581781/ https://www.ncbi.nlm.nih.gov/pubmed/34777576 http://dx.doi.org/10.1177/17562848211053112 |
Ejemplares similares
-
Vedolizumab Is Associated with Longer Drug Sustainability Compared to Infliximab in Moderate-to-Severe Ulcerative Colitis: Long-Term Real-World Cohort Data
por: Konikoff, Tom, et al.
Publicado: (2023) -
A Real-World Prospective Cohort Study of Patients With Newly Diagnosed Crohn’s Disease Treated by a Multidisciplinary Team: 1-Year Outcomes
por: Yanai, Henit, et al.
Publicado: (2023) -
Pregnancy Outcomes in a Cohort of Patients with Inflammatory Bowel Disease: Data from a Multidisciplinary Clinic in a Tertiary Center
por: Avni Biron, Irit, et al.
Publicado: (2023) -
Serologic Response and Safety after a Third Dose of the COVID-19 BNT162b2 Vaccine in Patients with Inflammatory Bowel Diseases
por: Edelman-Klapper, Hadar, et al.
Publicado: (2023) -
Ixekizumab Survival in Heavily Pretreated Patients with Psoriasis: A Two-year Single-centre Retrospective Study
por: SHERMAN, Shany, et al.
Publicado: (2020)